Levofloxacina Krka

Levofloxacin, the active ingredient in Levofloxacina Krka, is a fluoroquinolone antibiotic presented as an oral formulation for systemic use. It treats a range of bacterial infections in adults, including urinary tract, respiratory, skin, and intra‑abdominal infections, and is indicated for both uncomplicated and complicated cases.

GNH USA supplies Levofloxacina Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacina Krka is a broad‑spectrum fluoroquinolone used to manage bacterial infections across several organ systems. - Urinary tract infections: eradicates susceptible uropathogens, relieving dysuria and preventing recurrence. - Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible bacteria. - Skin and soft tissue infections: resolves cellulitis, abscesses, and wound infections. - Prostatitis: eliminates bacterial involvement in chronic bacterial prostatitis. - Complicated intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic organisms.

Levofloxacina Krka may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Photosensitivity: increased skin sensitivity to sunlight. - Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, often linked to sudden activity. - QT interval prolongation: may precipitate cardiac arrhythmias. - Severe allergic reactions: including anaphylaxis and Stevens‑Johnson syndrome. - Clostridioides difficile infection: colitis due to gut flora disruption. - Peripheral neuropathy: tingling or numbness in extremities. - Hepatic toxicity: elevated liver enzymes or jaundice.

Before prescribing Levofloxacina Krka, clinicians should consider several safety aspects. - Renal function: adjust dosing in patients with severe renal impairment. - History of tendon disorders: avoid use in individuals with prior tendon injury. - Cardiac risk: monitor QT interval in patients with known prolongation or on other QT‑prolonging drugs. - Concomitant antacids or supplements: separate administration by at least two hours to ensure absorption. - Pregnancy and lactation: reserve for situations where benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levofloxacina Krka can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk. - Theophylline: levofloxacin can raise theophylline levels, leading to toxicity. - Antacids or supplements containing aluminum, magnesium, calcium, or iron: significantly decrease levofloxacin absorption.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use may increase risk of tendon rupture. - Cyclosporine: levofloxacin may raise cyclosporine concentrations, necessitating therapeutic monitoring.